Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men

Abstract

Clinical and laboratory findings were compared in 65 women and 238 men with invasively documented idiopathic dilated cardiomyopathy. Women had more severe symptoms (New York Heart Association class ≥III in 48 vs 39%; p < 0.05), presented more frequently with heart failure signs (63 vs 41%; p < 0.01), and had a higher cardiothoracic ratio (0.56 ± 0.06 vs 0.53 ± 0.06; p < 0.05) and higher frequency of left bundle branch block (41 vs 29%; p < 0.05). Echocardiographic measurements in women showed significantly greater left ventricular (LV) end-diastolic (42 ± 7 vs 39 ± 6 mm/m 2; p < 0.0001) and end-systolic (36 ± 7 vs 33 ± 6 mm/m 2; p < 0.001) diameters, and mean myocardial thickness (11 ± 2 vs 10 ± 2 mm; p < 0.05). Exercise duration was shorter in women than in men (7 ± 3 vs 10 ± 4 minutes; p < 0.001). After 18 ± 16 months, 9 women and 27 men died, and 7 and 17, respectively, received transplants. Transplant-free survival was not significantly different according to gender. By Cox multivariate analysis, LV ejection fraction was a significant independent predictor of cardiac death or heart transplantation in both sexes (p < 0.05 in men, and p < 0.005 in women), together with left atrial diameter index (p < 0.01) in women, and mean pulmonary artery pressure (p < 0.001) in men. In conclusion, women with idiopathic dilated cardiomyopathy present a more advanced phase of the disease with greater LV dilation, but do not have a different prognosis.